Cost of heart failure management in Turkey: results of a Delphi Panel

Objective: To analyze health-related cost of heart failure (HF) and to evaluate health-related source utilization aiming to provide data on the economic burden of HF in actual clinical practice in Turkey. Methods: The study used the Delphi process of seeking expert consensus of opinion including 11 cardiologists who are experienced in HF. The standardized questionnaire comprised items to reflect the opinion of the expert panelists on the distribution of the HF patients in terms of demographic and clinical characteristics and background disease states. Costs related to out-patient follow-up, in-patient follow-up, medications, and other therapies were also evaluated. Results: 34.1% of the HF patients were in the age range of 60-69 years, and 62.3% were males. Coronary heart disease was the leading cause of HF (59.6%); 63.6% of the HF patients had reduced ejection fraction (rEF) and 42.3% were in New York Heart Association (NYHA)-II class. Approximately 75 % of the patients were followed up by a cardiology unit. The total annual visit number was estimated as 3.41. Approximately 32% of HF patients were hospitalized 1.64 times a year, for an average of 6.77 days each time. The total annual costs of all HF patients and HF-rEF patients were estimated as 1.537 TL and as 2.141 TL, respectively. Conclusion: The analysis demonstrating the magnitude of the economic impact of HF management on Turkey's healthcare system may help facilitate health and social policy interventions to improve the prevention and treatment of HF.

Yazar Aras, Dursun
Aydogdu, Sinan
Bozkurt, Engin
Cavusoglu, Yuksel
Eren, Mehmet
Erol, Cetin
Gulec, Sadi
Yayın Türü Article
Tek Biçim Adres https://hdl.handle.net/20.500.12628/2321
Tek Biçim Adres 10.14744/AnatolJCardiol.2016.6999
Konu Başlıkları heart failure
cost
economic burden
Turkey
Delphi
Koleksiyonlar Araştırma Çıktıları | WoS | Scopus | TR-Dizin | PubMed | SOBİAD
PubMed İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu
Dergi Adı ANATOLIAN JOURNAL OF CARDIOLOGY
Dergi Cilt Bilgisi 16
Dergi Sayısı 8
Sayfalar 554 - 562
Yayın Yılı 2016
Eser Adı
[dc.title]
Cost of heart failure management in Turkey: results of a Delphi Panel
Yazar
[dc.contributor.author]
Aras, Dursun
Yazar
[dc.contributor.author]
Aydogdu, Sinan
Yazar
[dc.contributor.author]
Bozkurt, Engin
Yazar
[dc.contributor.author]
Cavusoglu, Yuksel
Yazar
[dc.contributor.author]
Eren, Mehmet
Yazar
[dc.contributor.author]
Erol, Cetin
Yazar
[dc.contributor.author]
Gulec, Sadi
Yayın Yılı
[dc.date.issued]
2016
Yayıncı
[dc.publisher]
TURKISH SOC CARDIOLOGY
Yayın Türü
[dc.type]
article
Özet
[dc.description.abstract]
Objective: To analyze health-related cost of heart failure (HF) and to evaluate health-related source utilization aiming to provide data on the economic burden of HF in actual clinical practice in Turkey. Methods: The study used the Delphi process of seeking expert consensus of opinion including 11 cardiologists who are experienced in HF. The standardized questionnaire comprised items to reflect the opinion of the expert panelists on the distribution of the HF patients in terms of demographic and clinical characteristics and background disease states. Costs related to out-patient follow-up, in-patient follow-up, medications, and other therapies were also evaluated. Results: 34.1% of the HF patients were in the age range of 60-69 years, and 62.3% were males. Coronary heart disease was the leading cause of HF (59.6%); 63.6% of the HF patients had reduced ejection fraction (rEF) and 42.3% were in New York Heart Association (NYHA)-II class. Approximately 75 % of the patients were followed up by a cardiology unit. The total annual visit number was estimated as 3.41. Approximately 32% of HF patients were hospitalized 1.64 times a year, for an average of 6.77 days each time. The total annual costs of all HF patients and HF-rEF patients were estimated as 1.537 TL and as 2.141 TL, respectively. Conclusion: The analysis demonstrating the magnitude of the economic impact of HF management on Turkey's healthcare system may help facilitate health and social policy interventions to improve the prevention and treatment of HF.
Açıklama
[dc.description]
WOS: 000384427500003
Açıklama
[dc.description]
PubMed: 27515102
Kayıt Giriş Tarihi
[dc.date.accessioned]
2019-12-23
Açık Erişim Tarihi
[dc.date.available]
2019-12-23
Yayın Dili
[dc.language.iso]
eng
Konu Başlıkları
[dc.subject]
heart failure
Konu Başlıkları
[dc.subject]
cost
Konu Başlıkları
[dc.subject]
economic burden
Konu Başlıkları
[dc.subject]
Turkey
Konu Başlıkları
[dc.subject]
Delphi
Haklar
[dc.rights]
info:eu-repo/semantics/openAccess
ISSN
[dc.identifier.issn]
2149-2263
ISSN
[dc.identifier.issn]
2149-2271
İlk Sayfa Sayısı
[dc.identifier.startpage]
554
Son Sayfa Sayısı
[dc.identifier.endpage]
562
Dergi Adı
[dc.relation.journal]
ANATOLIAN JOURNAL OF CARDIOLOGY
Dergi Sayısı
[dc.identifier.issue]
8
Dergi Cilt Bilgisi
[dc.identifier.volume]
16
Tek Biçim Adres
[dc.identifier.uri]
https://dx.doi.org/10.14744/AnatolJCardiol.2016.6999
Tek Biçim Adres
[dc.identifier.uri]
https://hdl.handle.net/20.500.12628/2321
Görüntülenme Sayısı ( Şehir )
Görüntülenme Sayısı ( Ülke )
Görüntülenme Sayısı ( Zaman Dağılımı )
Görüntülenme
207
09.12.2022 tarihinden bu yana
İndirme
1
09.12.2022 tarihinden bu yana
Son Erişim Tarihi
14 Temmuz 2024 10:40
Google Kontrol
Tıklayınız
patients expert Approximately annual disease Turkey estimated clinical health-related economic opinion follow-up hospitalized number Objective cardiology followed (NYHA)-II Association facilitate management healthcare system health magnitude social policy interventions improve prevention treatment impact demonstrating average analysis
6698 sayılı Kişisel Verilerin Korunması Kanunu kapsamında yükümlülüklerimiz ve çerez politikamız hakkında bilgi sahibi olmak için alttaki bağlantıyı kullanabilirsiniz.

creativecommons
Bu site altında yer alan tüm kaynaklar Creative Commons Alıntı-GayriTicari-Türetilemez 4.0 Uluslararası Lisansı ile lisanslanmıştır.
Platforms